Evidence map›Paper›PMID 25315114›Full record

ArticlePhysiological genomics2014

TNF-α alters the release and transfer of microparticle-encapsulated miRNAs from endothelial cells.

Tamas Alexy, Kimberly Rooney, Martina Weber, Warren D Gray, Charles D Searles

Abstract read
In one paragraph

Article in Physiological genomics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. MicroRNA regulation of cholesterol metabolism.Annals of the New York Academy of Sciences · 2021
    Review
  9. Review
  10. Article
  11. Article
  12. MiR-502 Suppresses TNF-BioMed research international · 2021
    Article
  13. Article
  14. Review
  15. Review
  16. Resistin and Cardiac Arrest-A Prospective Study.Journal of clinical medicine · 2019
    Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Tamas AlexyDivision of Cardiology, Emory University School of Medicine, Atlanta, Georgia; and.
Kimberly RooneyDivision of Cardiology, Emory University School of Medicine, Atlanta, Georgia; and.
Martina WeberDivision of Cardiology, Emory University School of Medicine, Atlanta, Georgia; and.
Warren D GrayDivision of Cardiology, Emory University School of Medicine, Atlanta, Georgia; and.
Charles D SearlesDivision of Cardiology, Emory University School of Medicine, Atlanta, Georgia; and Section of Cardiology, Atlanta VA Medical Center, Decatur, Georgia csearle@emory.edu.
Emory University · USAtlanta VA Medical Center · US

Funding

Modulation of Endothelial Cell Function by the Shear Stress-Responsive miR-155R01HL109559 · NHLBI · EMORY UNIVERSITY · PI SEARLES, CHARLES D · 2011 to 2014
$1.3M
The Impact of miR-21 Expression on Endothelial Cell Apoptosis and InflammationI01BX000704 · VA · VETERANS HEALTH ADMINISTRATION · PI SEARLES, CHARLES D · 2011 to 2014
–
BLRD VA I01 BX000704NHLBI NIH HHS HL-109559NHLBI NIH HHS R01 HL109559
6 · The paper itself

Abstract

MicroRNAs (miRNAs) encapsulated within microparticles (MPs) are likely to have a role in cell-to-cell signaling in a variety of diseases, including atherosclerosis. However, little is known about the mechanisms by which different cell types release and transfer miRNAs. Here, we examined TNF-α-induced release of MP-encapsulated miR-126, miR-21, and miR-155 from human aortic endothelial cells (ECs) and their transfer to recipient cells. ECs were treated with TNF-α (100 ng/ml) in the presence or absence of inhibitors that target different MP production pathways. MPs released in response to TNF-α were characterized by: 1) 70-80% decrease in miRNA/MP levels for miR-126 and -21 but a significant increase in pre-miR-155 and miR-155 (P < 0.05), 2) 50% reduction in uptake by recipient cells (P < 0.05), and 3) diminished ability to transfer miRNA to recipient cells. Cotreatment of donor ECs with TNF-α and caspase inhibitor (Q-VD-OPH, 10 μM) produced MPs that had: 1) 1.5- to 2-fold increase in miRNA/MP loading, 2) enhanced uptake by recipient cells (2-fold), and 3) increased ability to transfer miR-155. Cotreatment of ECs with TNF-α and Rho-associated kinase (ROCK) inhibitor (10 μM) produced MPs with features similar to those produced by TNF-α treatment alone. Our data indicate that TNF-α induced the production of distinct MP populations: ROCK-dependent, miRNA-rich MPs that effectively transferred their cargo and were antiapoptotic, and caspase-dependent, miRNA-poor MPs that were proapoptotic. These data provide insight into the relationship between MP production and extracellular release of miRNA, as well as the potential of encapsulated miRNA for cell-to-cell communication.

Indexed as

AortaCaspase InhibitorsCaspasesCell-Derived MicroparticlesEndothelial CellsHumansMicroRNAsPhenotyperho-Associated KinasesTumor Necrosis Factor-alphaCaspase InhibitorsCaspasesMicroRNAsMIRN126 microRNA, humanMIRN155 microRNA, humanMIRN21 microRNA, humanrho-Associated KinasesTumor Necrosis Factor-alphaatherosclerosisendothelial cellsextracellular RNAmicroparticlesmiRNA release and transferTNF-α

Identifiers

PMID25315114
PMCPMC4233284
OpenAlexW2011006753

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.